Literature DB >> 34895117

WITHDRAWN: A Review of the Rational and Current Evidence on Colchicinezzm321990for COVID-19

Hazem S Ghaith1, Mohamed Diaa Gabra2, Mohamed H Nafady3, Hamza Emad Elshawah4, Ahmed Negida5, Mohammad Amjad Kamal6.   

Abstract

Since the authors are not responding to the editor’s requests to fulfill the editorial requirement, therefore, the article has been withdrawn by the publisher. Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused. The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php. Bentham Science Disclaimer: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Year:  2021        PMID: 34895117     DOI: 10.2174/1381612827666211210142352

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  2 in total

Review 1.  NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes.

Authors:  Debashis Dutta; Jianuo Liu; Huangui Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2022-06-15

2.  Letter to the Editor Regarding "Colchicine Against SARS-CoV-2 Infection: What is the Evidence?"

Authors:  Josef Finsterer
Journal:  Rheumatol Ther       Date:  2022-06-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.